Core Insights - The article discusses the perspective of a retired income investor focused on generating passive income through high-yield stocks and funds, particularly dividend-paying assets [1] - The investor emphasizes the importance of making informed long-term investment decisions, especially after experiencing the Great Recession [1] Investment Strategy - The investor primarily seeks dividend-paying income stocks and funds, including Business Development Companies (BDCs), Real Estate Investment Trusts (REITs), Closed-End Funds (CEFs), and Exchange-Traded Funds (ETFs) to enhance retirement income [1] - The goal is to supplement retirement income beyond pension and Social Security benefits [1] Market Insights - The investor expresses a keen interest in market psychology and trends in technology and finance, indicating a holistic approach to understanding market dynamics [1] - The article highlights the unpredictability of market performance across different asset classes over time due to changing conditions [1]

Johnson & Johnson (NYSE:JNJ) is included among the 12 Best Dividend Paying Stocks to Buy Now. Johnson & Johnson’s (JNJ) Dividend Growth Record Strengthens its Role in Dividend Paying Stocks Johnson & Johnson (NYSE:JNJ) is a major player in the pharmaceutical and medical device industries, with a recent market value close to $425 billion. The company is also showing growth, as second-quarter revenue increased 5.8% from the previous year and earnings rose 18%. Until 2023, Johnson & Johnson (NYSE:JNJ) oper ...

Core Viewpoint - AbbVie Inc. is recognized as one of the best dividend-paying stocks, with a strong track record of consistent dividend growth and a solid pipeline of treatments [1][5]. Group 1: Dividend Performance - AbbVie has a current dividend yield of 2.9%, significantly higher than the broader market's 1.2% [2]. - The company has raised its dividend by an average annual rate of 7% over the past five years, with the annual payout reaching approximately $6.56 per share, up from $5.20 in 2021 and $3.59 in 2018 [3]. - AbbVie's payout ratio is less than 50%, providing flexibility for future dividend increases [3]. Group 2: Product Pipeline and R&D Investment - AbbVie has faced patent expirations on key products like Humira but has developed a robust pipeline of around 90 treatments [4]. - The company invested nearly $11 billion in research and development in 2024, focusing on treatments in mid to late stages of progress [4]. Group 3: Dividend History - AbbVie has consistently grown its dividends for 53 consecutive years, establishing itself as a reliable dividend stock [5].

Group 1 - Pfizer Inc. is recognized as one of the 12 Best Dividend Paying Stocks to buy currently [1] - The company reported a 10% year-over-year increase in revenue and a 30% rise in earnings per share for the second quarter [3] - Pfizer has a strong dividend history, having increased its dividends for 25 consecutive years, with a current quarterly dividend of $0.43 per share and a dividend yield of 7.16% as of September 19 [4] Group 2 - Pfizer is among the world's leading pharmaceutical companies, with significant resources dedicated to research and development [2] - The drug discovery and approval process is complex and time-consuming, with no guarantees despite substantial funding [2] - Management has raised the full-year 2025 adjusted diluted EPS guidance, indicating confidence in the company's strategic execution and shareholder returns [3]

Group 1 - The company focuses on timely dividend-paying stocks to assist investors in wealth accumulation [1] - The author has extensive experience as a Registered Investment Advisor and has published multiple investment-related books [1] - The company aims to provide a steady pace of financial growth for its clients through various investment strategies [1] Group 2 - The author has a background in corporate management, having spent 15 years at Georgia-Pacific Corp before starting their own ventures [1] - The company has a history of involvement in small business advisory roles, including an appointment by President Ronald Reagan [1] - The investment newsletter emphasizes the importance of personal investment planning and stock market analysis [1]

Group 1 - The company focuses on timely dividend-paying stocks to assist investors in wealth accumulation [1] - The author has extensive experience as a Registered Investment Advisor and has published multiple investment-related books [1] - The company aims to provide a steady pace of financial growth for its clients through various investment strategies [1] Group 2 - The author has a background in corporate management, having worked at Georgia-Pacific Corp for 15 years before starting their own ventures [1] - The company has a history of involvement in small business advisory, having been appointed to a national council overseeing the Small Business Administration [1]

Core Viewpoint - The article emphasizes the importance of dividend-paying stocks for steady wealth accumulation and highlights the author's extensive experience in investment advising and stock market analysis [1] Group 1: Author's Background - The author has over 10 years of experience as a Registered Investment Advisor and has authored multiple financial books [1] - Prior to becoming a Registered Investment Advisor, the author spent 15 years as a corporate manager at Georgia-Pacific Corp [1] - The author has also operated various businesses, including manufacturing and export marketing management [1] Group 2: Investment Philosophy - The mission of Guiding Mast Investments is to assist investors in maintaining a steady pace of wealth accumulation [1] - The focus is on timely selections of dividend-paying stocks, which are considered crucial for financial growth [1] - The author previously created an investment newsletter in the late 1990s that concentrated on dividend reinvestment plans (DRIPs) [1]

Uh Ed, we now have a market that uh you know is has kind of completed whatever uh we're going to call what happened in the spring, that severe correction. In fact, one of the fastest rebounds from a 15% plus pullback in the S&P 500 we've seen. What does that tell us.And I guess what is the overall market behavior suggest to you. Yeah, Mike, it certainly has been risk on since the the April lows. We went through a retesting period for a couple of weeks, but then once we got into late April, it's been very mu ...